Replies to post #126739 on Biotech Values

[mouton29]

Shares of Momenta Pharma (Nasdaq: MNTA) are plunging following a WSJ headline which reports Amphastar Pharma has received FDA approval for the generic version of Lovenox.

I can't seem to find the WSJ headline on the WSJ website, searching under MNTA as well as lovenox and Amphastar. Has anyone else had better luck?